The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.00
Bid: 4.00
Ask: 6.00
Change: 0.00 (0.00%)
Spread: 2.00 (50.00%)
Open: 5.00
High: 5.00
Low: 5.00
Prev. Close: 5.00
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment in Pharm2Farm Limited

8 Jul 2019 07:00

RNS Number : 7146E
Braveheart Investment Group plc
08 July 2019
 

8 July 2019

 

Braveheart Investment Group plc

("Braveheart" or the "Group")

 

Investment in Pharm2Farm Limited

 

Braveheart (AIM: BRH), the fund management and strategic investor group, is pleased to announce that it has acquired a 33 per cent. holding in Pharm2Farm Limited ("P2F"). P2F is a spin out from Nottingham Trent University ("NTU") and is based in Nottingham, UK.

 

NTU and P2F have developed and patented a process to increase the bioavailability of trace minerals in plant feeds. Their patented process uses nanotechnology to dramatically improve trace element take-up in both flower and crop farming. P2F produce and sell these products through an exclusive licence to this technology from NTU.

 

Since records began in the 1940's, the nutritional value of the UK's and worldwide crops has diminished dramatically. Many of the intensively grown foods produced can no longer be regarded to be 'as healthy' because they lack the levels of trace elements once present. P2F produces these specialist nutrients in a unique way so that plants can absorb them more effectively.

 

This pioneering technology was initially developed to enrich the nutritional value of potatoes, in conjunction with the Agriculture and Horticulture Development Board ("AHDB") which represents farmers. Preliminary results not only showed a 20 per cent. increase in iron uptake by the tubers, but also an increase in yield and an approximate two-week reduction in the time to harvest. This patented technology has now been developed for use in the growing of other commercial crops, both in soil and hydroponically.

 

The worldwide hydroponics market alone is estimated to be $8.1 billion in 2019 and is expected to continue to grow at a compound annual growth rate of over 12 per cent. to $16.0 billion by 2025, with the EU remaining the largest market for hydroponically produced crops.

The Board of Braveheart believes there is a substantial market opportunity for this technology and is in negotiations to take the Group's shareholding in P2F to 54 per cent. by way of a working capital investment.

 

 

For further information:

 

Braveheart Investment Group plcTrevor Brown, Chief Executive Officer

 

 

Tel: 01738 587555

Allenby Capital Limited (Nominated Adviser and Joint Broker) David Worlidge / Nicholas Chambers

 

Tel: 020 3328 5656

 

 

Peterhouse Capital Limited (Joint Broker) Heena Karani / Lucy Williams

 

Tel: 020 7469 0936

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQCKODKCBKDPOK
Date   Source Headline
4th Feb 20137:00 amRNSSubsidiary and office name change
25th Jan 20137:00 amRNSEnvestors sets Fertility Focus on growth path
31st Dec 201211:15 amRNSTotal Voting Rights
19th Dec 20124:00 pmRNSIssue of Equity
14th Dec 20127:00 amRNSEnvestors members invest in eReceipts
4th Dec 20127:00 amRNSCyCell dials up Envestors for growth funding
3rd Dec 20127:00 amRNSHalf Yearly Report
28th Sep 20127:00 amRNSEnvestors closes equity funding round for Capablue
26th Sep 20127:00 amRNSAward of options
25th Sep 20122:49 pmRNSResult of AGM
4th Sep 20127:00 amRNSAward of options
31st Aug 20127:00 amRNSNotice of AGM
30th Aug 20127:00 amRNSEnvestors closes MoBank funding
29th Aug 20127:00 amRNSMandate to manage Lachesis Fund
13th Aug 20127:00 amRNSPreliminary Results
29th Jun 20127:00 amRNSChange of Adviser
27th Jun 20127:00 amRNSmLED secures further equity backing
11th Jun 20127:00 amRNSAward of fund management contract
31st May 201212:58 pmRNSDirector/PDMR Shareholding
31st May 20127:00 amRNSEnvestors deal backs Squease
29th May 20127:00 amRNSDirector/PDMR Shareholding
28th May 20129:00 amRNSDirector/PDMR Shareholding
28th May 20129:00 amRNSGrant of Options
18th May 20127:00 amRNSUpdate - appointment to manage £50m loan fund
11th May 20127:00 amRNSIssue of equity and placing of shares
8th May 20127:00 amRNSEnvestors closes Style-Passport funding
18th Apr 20127:00 amRNSEnvestors launches Isle of Man service
5th Apr 20127:00 amRNSIssue of Equity and Placing of Shares
23rd Mar 20127:00 amRNSAcquisition
21st Mar 20127:00 amRNSAppointment of joint broker
29th Feb 20127:00 amRNSAppointment to manage £50m loan fund
29th Dec 20117:00 amRNSHalf Yearly Report
22nd Dec 20117:00 amRNSFurther investment in AppShare
20th Dec 20117:00 amRNSFurther investment in Conjunct
8th Dec 20117:00 amRNSEnvestors secures Cherrygood funding
24th Nov 20117:00 amRNSEnvestors secures £450,000 eReceipts funding
10th Nov 20117:00 amRNSE-learning transaction
23rd Sep 20117:00 amRNSFurther investment in Chargemaster Plc
15th Sep 20113:10 pmRNSResult of AGM
7th Sep 20117:00 amRNSInvestment in Olly Limited
22nd Aug 20117:00 amRNSNotice of AGM
19th Aug 20117:00 amRNSFurther investment in Design LED Products
26th Jul 20117:00 amRNSFinal Results
22nd Jul 20117:00 amRNSNotice of Results
1st Jul 20114:06 pmRNSHolding(s) in Company
1st Jul 20113:58 pmRNSHolding(s) in Company
29th Jun 20117:00 amRNSDevelopment of business angel network
27th Jun 201111:39 amRNSHolding(s) in Company
27th Jun 201111:38 amRNSHolding(s) in Company
23rd Jun 20117:00 amRNSIssue of equity and placing of shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.